Preventicus Heartbeats

0
Preventicus Heartbeats
Preventicus Heartbeats is an Android app from Preventicus GmbH in the Medical category, currently rated — across few ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Medical app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Synthetic estimate. Multiple band derived from iap / freemium model + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 💎 IAP / freemium model base | 28× MRR |
| 🏷 Medical category multiple | +12% |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷 Category context | Medical |
| 📦 Compact Android bundle | → Native Kotlin |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Early-stage solo · 41/100INDIE TIERexpected for tier- 💰 Revenue: Marginal — $230 - $1438/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Preventicus Heartbeats
- Developer
- Preventicus GmbH
- Bundle ID
- com.preventicus.heartbeats
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.preventicus.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $575/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $1.99 - $47.99 per item
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
That's what Preventicus Heartbeats is all about:
- No other devices: the smartphone camera alone is used to analyse the heart rhythm in detail. Can be carried out anytime and anywhere.
- We won't leave you on your own: After the measurement, you will receive a detailed analysis including recommendations for action. Abnormal results can be reviewed by our medical experts.… View full description on the official store →
Tech & Domain Intel — preventicus.com
- Mail provider
- Microsoft 365
- Tech stack
- Atlassian (Jira/Confluence) · Microsoft 365 · Apple Pay / Sign in with Apple · Meta (Facebook) Ads · Google Workspace
Track this app’s revenue
FREE📝 Description
95
More by Preventicus GmbH
View all →Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Preventicus Heartbeats is a very early-stage Android app in the medical space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




